Clinical trial
Renoprotective Effect of Nisoldipine and Lisinopril in Type 1 Diabetic…
NCT00311870 · Steno Diabetes Center Copenhagen, Other · Completed
Key facts
| NCT number | NCT00311870 |
|---|---|
| Title | Renoprotective Effect of Nisoldipine and Lisinopril in Type 1 Diabetic Nephropathy |
| Lead sponsor | Steno Diabetes Center Copenhagen, Other |
| Collaborators | Bayer Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Diabetic Nephropathy |
| Intervention type | Drug |
| Interventions | nisoldipine, lisinopril |
| Enrollment | 52 |
| Start date | Mar 1, 1993 |
| Completion | Apr 1, 1999 |
| First posted | Apr 6, 2006 |
| Last update posted | Apr 6, 2006 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: